Effect of Calmodulin and Protein Kinase C Inhibitors on Globally Ischemic Rat Hearts

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  1992-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-199208000-00010PMID 1381016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of chloride channels in normal and cystic fibrosis airway epithelial cells by multifunctional calcium/calmodulin-dependent protein kinase

  1991cited by this paper
• Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.

  1991cited by this paper
• Comparative anti-ischemic effects of dihydropyridine calcium antagonists in isolated perfused rat hearts: relationship of cardiodepression and cardioprotection.

  1990cited by this paper
• Reduction in infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion.

  1990cited by this paper
• Staurosporine, a Novel Protein Kinase C Inhibitor, Prevents Postischemic Neuronal Damage in the Gerbil and Rat

  1990cited by this paper
• Pharmacologic Profile of Cromakalim in the Treatment of Myocardial Ischemia in Isolated Rat Hearts and Anesthetized Dogs

  1990cited by this paper
• Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.

  1989cited by this paper
• Anti-ischemic and membrane stabilizing activity of calmodulin inhibitors

  1989cited by this paper
• Improvement of ischemia-reperfusion-induced myocardial dysfunction by modulating calcium-overload using a novel, specific calmodulin antagonist, CGS 9343B.

  1989cited by this paper
• Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.

  1989cited by this paper
• Calmodulin Modulation of Single Sarcoplasmic Reticulum Ca2+‐Release Channels From Cardiac and Skeletal Muscle

  1989cited by this paper
• Dissociation of Cardiodepression from Cardioprotection with Calcium Antagonists: Diltiazem Protects Ischemic Rat Myocardium with a Lower Functional Cost as Compared with Verapamil or Nifedipine

  1989cited by this paper
• Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis.

  1988cited by this paper
• Effects of diltiazem upon globally ischemic rat hearts.

  1987cited by this paper
• CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity.

  1987cited by this paper
• Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

  1986cited by this paper
• Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function.

  1985cited by this paper
• Effect of Reperfusion Late in the Phase of Reversible Ischemic Injury: Changes in Cell Volume, Electrolytes, Metabolites, and infrastructure

  1985cited by this paper
• Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

  1984cited by this paper
• Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists.

  1984cited by this paper
• Effects of various calmodulin antagonists on contraction of rabbit aortic strips.

  1982cited by this paper
• Modulation of platelet shape and membrane receptor binding by Ca2+–calmodulin complex

  1981cited by this paper
• Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs.

  1981cited by this paper
• R 24571: a new powerful inhibitor of red blood cell Ca++-transport ATPase and of calmodulin-regulated functions.

  1981cited by this paper
• Cross-linking of iodine-125-labeled, calcium-dependent regulatory protein to the Ca2+-sensitive phosphodiesterase purified from bovine heart.

  1979cited by this paper
• Calmodulin stimulates human platelet phospholipase A2.

  1979cited by this paper
• Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate dependent and calcium--calmodulin-dependent phosphorylations.

  1979cited by this paper
• Purification and characterization of bovine cardiac calmodulin-dependent myosin light chain kinase.

  1979cited by this paper
• Release of alpha hydroxybutyrate from neonatal rat heart cell cultures exposed to anoxia and reoxygenation: comparison with impairment of structure and function of damaged cardiac cells.

  1979cited by this paper
• Lactic Dehydrogenase Activity in Blood.∗

  1955cited by this paper

• The Urocortins: mechanisms of cardioprotection and therapeutic potential.

  2006cites this paper
• Clinical implications of apoptosis in ischemic myocardium.

  2006cites this paper
• Cardioprotection mediated by urocortin is dependent upon PKCε activation

  2005cites this paper
• Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology

  2004cites this paper
• Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat

  2001cites this paper
• Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.

  1999cites this paper
• Identification of specific nuclear protein kinase C isozymes and accelerated protein kinase C‐dependent nuclear protein phosphorylation during myocardial ischemia

  1998cites this paper
• Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy.

  1998cites this paper
• The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Anti-ischemic effect and therapeutic window.

  1997cites this paper
• Enalaprilat, an angiotensin-converting enzyme inhibitor, enhances functional preservation during long-term cardiac preservation. Possible involvement of bradykinin and PKC.

  1996cites this paper
• Direct measurement of nitric oxide release from vascular endothelial cells.

  1996cites this paper
• Effects of a 100% perfluorooctylbromide emulsion on ischemia/reperfusion injury following cardioplegia.

  1995cites this paper
• Calcium-binding proteins 1: EF-hands.

  1995cites this paper
• Does ischemic preconditioning trigger translocation of protein kinase C in the canine model?

  1995cites this paper
• Calcium-binding proteins. 1: EF-hands.

  1994cites this paper
• Serotonin-induced decrease in brain ATP, stimulation of brain anaerobic glycolysis and elevation of plasma hemoglobin; the protective action of calmodulin antagonists.

  1994cites this paper
• Treatment of muscle damage, induced by high intracellular Ca2+, with calmodulin antagonists.

  1993cites this paper
• Two subtypes of the endothelin receptor (ETA and ETB) mediate vasoconstriction in the perfused rat heart.

  1993cites this paper